APA citiranje

Park, S. E., Park, K., Lee, E., Kim, J., Ahn, J. S., Im, Y., . . . Park, Y. H. (2018). Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer. Oncoimmunology.

Citação norma Chicago

Park, Song Ee, et al. "Clinical Implication of Tumor Mutational Burden in Patients With HER2-positive Refractory Metastatic Breast Cancer." Oncoimmunology 2018.

MLA citiranje

Park, Song Ee, et al. "Clinical Implication of Tumor Mutational Burden in Patients With HER2-positive Refractory Metastatic Breast Cancer." Oncoimmunology 2018.